Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Neurocrine Biosciences, Inc. (NB3.F)

Compare
92.20
-3.86
(-4.02%)
At close: April 4 at 8:11:21 AM GMT+2
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
3,718,700
3,251,400
2,368,700
2,072,500
Total Liabilities Net Minority Interest
1,129,000
1,019,400
660,900
698,500
Total Equity Gross Minority Interest
2,589,700
2,232,000
1,707,800
1,374,000
Total Capitalization
2,589,700
2,232,000
1,707,800
1,709,100
Common Stock Equity
2,589,700
2,232,000
1,707,800
1,374,000
Capital Lease Obligations
455,100
258,300
93,500
105,300
Net Tangible Assets
2,553,200
2,196,500
1,670,600
1,374,000
Working Capital
1,217,000
952,200
915,800
727,000
Invested Capital
2,589,700
2,402,100
1,877,200
1,709,100
Tangible Book Value
2,553,200
2,196,500
1,670,600
1,374,000
Total Debt
455,100
428,400
262,900
440,400
Share Issued
99,400
98,700
96,500
94,900
Ordinary Shares Number
99,400
98,700
96,500
94,900
12/31/2021 - 1/27/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade